Fagron is the only multinational one-stop-shop for products and services for pharmaceutical compounding in Europe. It offers high-quality raw materials, semi-manufacture, ready products, services and concepts that fulfill the specific and individual wishes of pharmacists, hospitals and the pharmaceutical, cosmetic and veterinary industry. Fagron continuously invests in innovation and product development and consequently has a constant, adequate pipeline of new products that will be introduced to the market through increased sales and marketing activities.
Fagron continued to consolidate its European market leadership in the first half of 2009. Turnover grew 10.1% to € 73.3 million and REBITDA increased 11.9% to € 13.1 million, with organic growth of 3.6%. The greenfield operation started in the United Kingdom in 2007 moved into profit in the first half of 2009. These excellent results confirm the success of Fagron’s core values: innovation, quality and focus on solutions.
Fagron is currently operating in 16 European countries and holds a leadership position in nine countries. The company’s European market leadership presents major competitive advantages, such as central purchasing of raw materials and optimal utilisation of the company’s various production facilities.
The European market for pharmaceutical compounding is highly fragmented and is populated by only local players with a limited range of products and services. Fagron plans to use its European market leadership position to respond to the fragmented nature of the market by further expanding its European platform and to further roll-out the Fagron premium brand. This will be done by means of an active buy-and build strategy, by starting up Greenfield activities and through further organic growth. In addition to the further geographical expansion and consolidation opportunities in Western Europe, Fagron also has acquisition plans in Central and Eastern Europe and Scandinavia.
Fagron
